Home / About us / Leadership / Maja Malbasic, BSc

Maja Malbasic, BSc

Senior Quality and Compliance Manager

Maja graduated from Mount Saint Vincent University with a Bachelor of Science degree in Biology, along with minors in Chemistry and Mathematics. Her academic background provided her with a strong foundation in scientific principles, analytical thinking, and problem-solving skills that continue to support her work in the life sciences industry.

Prior to joining AGADA, Maja gained experience in quality assurance and regulatory affairs within a GMP laboratory environment, where she developed expertise in compliance, documentation, quality systems, and regulatory requirements. She has participated in multiple FDA audits, gaining valuable insight into regulatory expectations, inspection readiness, risk assessment, and the importance of maintaining the highest standards of quality and integrity within a regulated environment.

Maja heads up AGADA’s Quality Management System (QMS), maintaining compliance with regulatory standards and client requirements. With the responsibility of overseeing internal audits, risk assessments, document control and CAPA programs, Maja also partners with the scientific and laboratory teams to integrate quality controls directly into daily research workflows.

Get in touch

To learn how AGADA Biosciences could support your program, get in touch with our team and start the conversation.

Why AGADA?

We bring dedicated expertise to programs where there is little room for error, providing the scientific support, responsiveness and program fit that help rare disease teams move forward with clarity.

Decade of specialization:

Founded in 2013 as a spinout from Children’s National Medical Center to provide specialist scientific support for rare disease drug development.

Consistent audit success:

We successfully pass an average of five sponsor audits annually to support clinical trials across multiple phases.

Historical benchmarking:

We leverage archival data from over 100 trials in mouse models of muscular dystrophy to accurately power your efficacy studies.

Dedicated scale:

We operate with a team of approximately 50 employees, entirely focused on executing complex rare disease programs.

Meet more of the leadership team

Lianne Baker, BSc, BEd

Senior Facilities & Procurement Manager

Learn more

John Stapleton

Senior IT Manager

Learn more

Sadish Srinivassane, MSc, MVPH, DVM

Senior Training & Development Manager

Learn more

Chris Rice, BSc

Senior Quality Assurance Manager

Learn more